New tool could better track facial muscle health in rare muscle disease
NCT ID NCT06425445
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new method to evaluate the strength and function of face and mouth muscles in people with facioscapulohumeral muscular dystrophy (FSHD). Twenty-two adults with a genetic diagnosis of FSHD took part. The goal was to see if this new assessment tool can reliably measure muscle performance, which may help doctors monitor the disease more closely in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Mons
Mons, Hainaut, 7000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can MRI reveal the hidden progression of muscular dystrophy?
- Personalized exercise program aims to boost mobility in rare muscle diseases
- New tools aim to speed up FSHD drug trials
- New drug aims to build muscle in rare muscular dystrophy
- FSHD patients unite: new registry aims to accelerate research and care
- Sound waves could spot early signs of rare muscle disease